MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Hallucinations"

  • 2019 International Congress

    A possible case of prodromal DLB with prominent hallucinations, autonomic dysfunction, and REM behavior disorder but absence of cognitive impairment

    K. Amodeo (Rochester, NY, USA)

    Objective: Dementia with Lewy bodies (DLB) is the second most common cause of neurodegenerative dementia, after Alzheimer’s disease (AD). While mild cognitive impairment (MCI) is…
  • 2019 International Congress

    Cognitive dysfunction in patients with Parkinson’s disease and psychosis

    A. Lenka, S. Hegde, S. Arumugham, R. Yadav, P. Pal (Washington, DC, USA)

    Objective: The objective of this study was to explore the pattern of cognitive dysfunction in the patient's with Parkinson's disease and psychosis (PD-P) by comparing…
  • 2019 International Congress

    The effect of dopaminergic therapy on functional connectivity in patients with Parkinson’s disease and visual hallucinations

    A. Powell, J. Shine, S. Lewis (Sydney, Australia)

    Objective: To examine changes in functional connectivity in patients with Parkinson’s disease (PD) and visual hallucinations (VH) on and off dopaminergic medication. Background: Symptoms on…
  • 2019 International Congress

    Visual hallucinations in Parkinson´s disease and amyloid burden: 18F-Flutemetamol PET-MRI study

    B. Fernández-Rodríguez, C. Gasca-Salas, R. Rodríguez-Rojas, P. Guida, D. Mata-Marín, I. Obeso-Martín, L. Vela, M. Garcerant-Tafur, L. García-Cañamaque, JA. Obeso (Móstoles, Spain)

    Objective: To compare amyloid distribution in patients with Parkinson´s disease (PD) with visual hallucinations (VH-p) and without (VH-n). Background: In patients with PD the prevalence…
  • 2018 International Congress

    Motor and non-motor symptoms of a 7.5-year prospective study of patients with Parkinson’s disease

    A. Yoritaka, Y. Shimo, T. Hatano, N. Hattori (Saitama, Japan)

    Objective: Previously, we retrospectively reported the prevalence and risks of motor and non-motor symptoms of a large number of patients (1453) with Parkinson’s disease (PD)…
  • 2018 International Congress

    Visual hallucinations and autonomic burden are inversely associated with physical activity in PD

    J. Hinkle, K. Perepezko, N. Fischer, Z. Mari, L. Marsh, G. Pontone (Baltimore, MD, USA)

    Objective: To determine the neuropsychiatric and non-motor correlates of reduced physical activity in PD. Background: The motor symptoms of PD interfere with patients’ ability to…
  • 2018 International Congress

    Categorising visual hallucinations in early Parkinson’s disease

    B. Clegg, G. Duncan, T. Khoo, R. Barker, D. Burn, A. Yarnall, R. Lawson (Newcastle upon Tyne, United Kingdom)

    Objective: To categorise visual hallucinations (VHs) in a cohort of newly diagnosed Parkinson’s disease (PD) patients and determine associations with clinical characteristics. Background: Visual hallucinations…
  • 2018 International Congress

    Prevalence and risk factors for visual hallucinations in Chinese patients with Parkinson’s disease

    J. Zhu, L. Zhang (Nanjing, China)

    Objective: The aim of this study was to illuminate the prevalence and clinical correlates of VHs in the Chinese population with PD. Background: Parkinson's disease…
  • 2018 International Congress

    Identifying delirium and it prevalence in idiopathic Parkinson’s disease

    R. Lawson, C. McDonald, D. Burn (Newcastle upon Tyne, United Kingdom)

    Objective: To determine diagnostic criteria used to identify delirium in Parkinson’s disease (PD) and its prevalence via a systematic literature review. Background: People with PD…
  • 2018 International Congress

    Propranolol Induced Visual Hallucinations: A Case Report Charles Bonnets Syndrome in Parkinson Disease

    M. Şenol, M. Kendirli (Istanbul, Turkey)

    Objective: Charles Bonnets has defined the visual hallucinations (VH) associated with macular degeneration; the syndrome (CBS) is to be remembered by his name. M Background:…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 11
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley